WillisTCCarterBARogersSPHawthorneKMHicksPDAbramsSA. High rates of mortality and morbidity occur in infants with parenteral nutrition associated cholestasis. JPEN J Parenter Enteral Nutr. 2010;34:32-37.
2.
NehraDFallonEMPuderM. The prevention and treatment of intestinal failure–associated liver disease in neonates and children. Surg Clin North Am. 2011;91:543-563.
CoberMPTeitelbaumDH. Prevention of parenteral nutrition–associated liver disease: lipid minimization. Curr Opin Organ Transplant. 2010;15:330-333.
5.
NehraDFallonEMCarlsonSJ. Provision of a soy-based intravenous lipid emulsion at 1 g/kg/d does not prevent cholestasis in neonates. JPEN J Parenter Enteral Nutr. 2013;37:498-505.
